Knight Therapeutics Inc. announced the resignation of Hillel Rosen and the appointment Ed Schutter to Knight's Board of Directors. Ed Schutter is President and CEO of Arbor Pharmaceuticals, LLC. Prior to Arbor, Ed served as President of Sciele Pharmaceuticals.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.14 CAD | +0.66% | +3.72% | +18.30% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.30% | 455M | |
+11.98% | 9.08B | |
-10.76% | 5.06B | |
+53.60% | 4.85B | |
+7.56% | 3.85B | |
+14.09% | 2.37B | |
-21.42% | 2.36B | |
+25.03% | 2.27B | |
-30.36% | 2.22B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- GUD Stock
- News Knight Therapeutics Inc.
- Knight Therapeutics Inc. Announces Board Change